Table 3.
Differences in baseline characteristics of patients who with and without sICH
sICH (n = 34) | Non-sICH (n = 472) | p-value | |
---|---|---|---|
Female (n, %) | 15 (44.1%) | 163 (34.5%) | 0.258 |
Age (median, IQR), y | 73 (68-80) | 67 (58-74) | <0.001 |
Current smoker (n, %) | 7 (20.6%) | 133 (28.2%) | 0.339 |
Hypertension (n, %) | 25 (73.5%) | 317 (67.2%) | 0.444 |
Hyperlipidemia (n, %) | 7 (20.6%) | 176 (37.3%) | 0.05 |
Diabetes (n, %) | 12 (35.3%) | 100 (21.2%) | 0.056 |
Chronic heart failure (n, %) | 9 (26.5%) | 86 (18.2%) | 0.234 |
Atrial fibrillation (n, %) | 25 (73.5%) | 137 (29.0%) | <0.001 |
Previous ischemic stroke (n, %) | 4 (11.8%) | 63 (13.3%) | 0.999 |
Baseline SBP (mmHg, median, IQR) | 142 (133-169) | 149 (134-163) | 0.573 |
Baseline blood glucose (mmol/L, median, IQR) | 8.1 (6.5-11.6) | 6.8 (5.9-8.3) | 0.004 |
Baseline blood glucose ≥ 10mmol/L (n, %) | 10 (29.4%) | 67 (14.2%) | 0.017 |
Baseline MCA hypertense sign (n, %)* | 2 (6.3%) | 24 (5.2%) | 0.684 |
Type of occluded vessel (n, %) | 0.203 | ||
Anterior | 30 (88.2%) | 355 (75.5%) | |
Posterior | 0 | 45 (9.6%) | |
Mixed | 3 (8.8%) | 39 (8.3%) | |
Onset to thrombolysis time (min)† | 169 (123-210) | 173 (120-210) | 0.951 |
Baseline NIHSS score (median, IQR) | 14 (9.5-17.5) | 5 (3-11) | <0.001 |
Low-dose (n, %) | 2 (5.9%) | 94 (19.9%) | 0.074 |
Abbreviations: MCA, middle cerebral artery; NIHSS, national institute of health stroke scale; SBP, systolic blood pressure; sICH, symptomatic intracerebral hemorrhage;
*Data available in 490 patients;
†Data available in 470 patients.